trial · primary record
adebrelimab
Esophageal Squamous Cell Carcinoma
| Phase | Phase 2 |
|---|---|
| Status | RECRUITING |
| Sponsor | Unknown |
| Enrolment | 48 |
| Primary completion | 2028-12 |
| Primary endpoint | cCR |
| Registry ID | NCT06510660 |
Provenance
- Source: ClinicalTrials.gov
- Fetched at: 2026-10-28T03:28:08.455Z
- Licence class: attribution-required
- Verdict: primary-source
- Entity id: NCT06510660
This record is rendered from the AEaH spine. If the source is unreachable the page is not generated.